Global Radiopharmaceutical Theranostics Market Research Report 2025(Status and Outlook)

March 2025 | 238 pages | ID: G4B6A9C8436CEN
Bosson Research

Abstracts

Report Overview

Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.

This report provides a deep insight into the global Radiopharmaceutical Theranostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceutical Theranostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceutical Theranostics market in any manner.

Global Radiopharmaceutical Theranostics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Nihon Medi-Physics

ITM Isotopen Technologien Mьnchen AG

Advanced Accelerator Applications

Telix Pharmaceuticals

GE Healthcare

Theragnostics Ltd.

NuView Life Sciences

Jubilant Pharma Limited

Lantheus Holdings

Inc.

Curium Pharma

Bayer AG

Clarity Pharmaceuticals

Market Segmentation (by Type)

Oncology

Cardiology

Others

Market Segmentation (by Application)

Hospitals

Academic & Research Institutes

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Radiopharmaceutical Theranostics Market
• Overview of the regional outlook of the Radiopharmaceutical Theranostics Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Theranostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Radiopharmaceutical Theranostics
1.2 Key Market Segments
  1.2.1 Radiopharmaceutical Theranostics Segment by Type
  1.2.2 Radiopharmaceutical Theranostics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL RADIOPHARMACEUTICAL THERANOSTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Radiopharmaceutical Theranostics Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Radiopharmaceutical Theranostics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL RADIOPHARMACEUTICAL THERANOSTICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceutical Theranostics Product Life Cycle
3.3 Global Radiopharmaceutical Theranostics Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceutical Theranostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceutical Theranostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceutical Theranostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Radiopharmaceutical Theranostics Manufacturing Sites, Area Served, Product Type
3.8 Radiopharmaceutical Theranostics Market Competitive Situation and Trends
  3.8.1 Radiopharmaceutical Theranostics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Radiopharmaceutical Theranostics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 RADIOPHARMACEUTICAL THERANOSTICS INDUSTRY CHAIN ANALYSIS

4.1 Radiopharmaceutical Theranostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICAL THERANOSTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceutical Theranostics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Radiopharmaceutical Theranostics Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL RADIOPHARMACEUTICAL THERANOSTICS MARKET BY REGION

6.1 Global Radiopharmaceutical Theranostics Market Size by Region
  6.1.1 Global Radiopharmaceutical Theranostics Market Size by Region
  6.1.2 Global Radiopharmaceutical Theranostics Market Size Market Share by Region
6.2 Global Radiopharmaceutical Theranostics Sales by Region
  6.2.1 Global Radiopharmaceutical Theranostics Sales by Region
  6.2.2 Global Radiopharmaceutical Theranostics Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Radiopharmaceutical Theranostics Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Radiopharmaceutical Theranostics Market Size by Type
7.3 North America Radiopharmaceutical Theranostics Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Radiopharmaceutical Theranostics Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Radiopharmaceutical Theranostics Market Size by Type
8.3 Europe Radiopharmaceutical Theranostics Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Type
9.3 Asia-Pacific Radiopharmaceutical Theranostics Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Radiopharmaceutical Theranostics Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Radiopharmaceutical Theranostics Market Size by Type
10.3 South America Radiopharmaceutical Theranostics Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Radiopharmaceutical Theranostics Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Radiopharmaceutical Theranostics Market Size by Type
11.3 Middle East and Africa Radiopharmaceutical Theranostics Market Size by Application

12 RADIOPHARMACEUTICAL THERANOSTICS MARKET PRODUCTION BY REGION

12.1 Global Production of Radiopharmaceutical Theranostics by Region(2020-2025)
12.2 Global Radiopharmaceutical Theranostics Revenue Market Share by Region (2020-2025)
12.3 Global Radiopharmaceutical Theranostics Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Radiopharmaceutical Theranostics Production
  12.4.1 North America Radiopharmaceutical Theranostics Production Growth Rate (2020-2025)
  12.4.2 North America Radiopharmaceutical Theranostics Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Radiopharmaceutical Theranostics Production
  12.5.1 Europe Radiopharmaceutical Theranostics Production Growth Rate (2020-2025)
  12.5.2 Europe Radiopharmaceutical Theranostics Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Radiopharmaceutical Theranostics Production (2020-2025)
  12.6.1 Japan Radiopharmaceutical Theranostics Production Growth Rate (2020-2025)
  12.6.2 Japan Radiopharmaceutical Theranostics Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Radiopharmaceutical Theranostics Production (2020-2025)
  12.7.1 China Radiopharmaceutical Theranostics Production Growth Rate (2020-2025)
  12.7.2 China Radiopharmaceutical Theranostics Production, Revenue, Price and Gross Margin (2020-2025)

13 RADIOPHARMACEUTICAL THERANOSTICS MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Radiopharmaceutical Theranostics Sales Market Share by Type (2020-2033)
13.3 Global Radiopharmaceutical Theranostics Market Size Market Share by Type (2020-2033)
13.4 Global Radiopharmaceutical Theranostics Price by Type (2020-2033)

14 RADIOPHARMACEUTICAL THERANOSTICS MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Radiopharmaceutical Theranostics Market Sales by Application (2020-2033)
14.3 Global Radiopharmaceutical Theranostics Market Size (M USD) by Application (2020-2033)
14.4 Global Radiopharmaceutical Theranostics Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Nihon Medi-Physics
  15.1.1 Nihon Medi-Physics Basic Information
  15.1.2 Nihon Medi-Physics Radiopharmaceutical Theranostics Product Overview
  15.1.3 Nihon Medi-Physics Radiopharmaceutical Theranostics Product Market Performance
  15.1.4 Nihon Medi-Physics Business Overview
  15.1.5 Nihon Medi-Physics SWOT Analysis
  15.1.6 Nihon Medi-Physics Recent Developments
15.2 ITM Isotopen Technologien Mьnchen AG
  15.2.1 ITM Isotopen Technologien Mьnchen AG Basic Information
  15.2.2 ITM Isotopen Technologien Mьnchen AG Radiopharmaceutical Theranostics Product Overview
  15.2.3 ITM Isotopen Technologien Mьnchen AG Radiopharmaceutical Theranostics Product Market Performance
  15.2.4 ITM Isotopen Technologien Mьnchen AG Business Overview
  15.2.5 ITM Isotopen Technologien Mьnchen AG SWOT Analysis
  15.2.6 ITM Isotopen Technologien Mьnchen AG Recent Developments
15.3 Advanced Accelerator Applications
  15.3.1 Advanced Accelerator Applications Basic Information
  15.3.2 Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Overview
  15.3.3 Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Market Performance
  15.3.4 Advanced Accelerator Applications Business Overview
  15.3.5 Advanced Accelerator Applications SWOT Analysis
  15.3.6 Advanced Accelerator Applications Recent Developments
15.4 Telix Pharmaceuticals
  15.4.1 Telix Pharmaceuticals Basic Information
  15.4.2 Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Overview
  15.4.3 Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Market Performance
  15.4.4 Telix Pharmaceuticals Business Overview
  15.4.5 Telix Pharmaceuticals Recent Developments
15.5 GE Healthcare
  15.5.1 GE Healthcare Basic Information
  15.5.2 GE Healthcare Radiopharmaceutical Theranostics Product Overview
  15.5.3 GE Healthcare Radiopharmaceutical Theranostics Product Market Performance
  15.5.4 GE Healthcare Business Overview
  15.5.5 GE Healthcare Recent Developments
15.6 Theragnostics Ltd.
  15.6.1 Theragnostics Ltd. Basic Information
  15.6.2 Theragnostics Ltd. Radiopharmaceutical Theranostics Product Overview
  15.6.3 Theragnostics Ltd. Radiopharmaceutical Theranostics Product Market Performance
  15.6.4 Theragnostics Ltd. Business Overview
  15.6.5 Theragnostics Ltd. Recent Developments
15.7 NuView Life Sciences
  15.7.1 NuView Life Sciences Basic Information
  15.7.2 NuView Life Sciences Radiopharmaceutical Theranostics Product Overview
  15.7.3 NuView Life Sciences Radiopharmaceutical Theranostics Product Market Performance
  15.7.4 NuView Life Sciences Business Overview
  15.7.5 NuView Life Sciences Recent Developments
15.8 Jubilant Pharma Limited
  15.8.1 Jubilant Pharma Limited Basic Information
  15.8.2 Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Overview
  15.8.3 Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Market Performance
  15.8.4 Jubilant Pharma Limited Business Overview
  15.8.5 Jubilant Pharma Limited Recent Developments
15.9 Lantheus Holdings
  15.9.1 Lantheus Holdings Basic Information
  15.9.2 Lantheus Holdings Radiopharmaceutical Theranostics Product Overview
  15.9.3 Lantheus Holdings Radiopharmaceutical Theranostics Product Market Performance
  15.9.4 Lantheus Holdings Business Overview
  15.9.5 Lantheus Holdings Recent Developments
15.10 Inc.
  15.10.1 Inc. Basic Information
  15.10.2 Inc. Radiopharmaceutical Theranostics Product Overview
  15.10.3 Inc. Radiopharmaceutical Theranostics Product Market Performance
  15.10.4 Inc. Business Overview
  15.10.5 Inc. Recent Developments
15.11 Curium Pharma
  15.11.1 Curium Pharma Basic Information
  15.11.2 Curium Pharma Radiopharmaceutical Theranostics Product Overview
  15.11.3 Curium Pharma Radiopharmaceutical Theranostics Product Market Performance
  15.11.4 Curium Pharma Business Overview
  15.11.5 Curium Pharma Recent Developments
15.12 Bayer AG
  15.12.1 Bayer AG Basic Information
  15.12.2 Bayer AG Radiopharmaceutical Theranostics Product Overview
  15.12.3 Bayer AG Radiopharmaceutical Theranostics Product Market Performance
  15.12.4 Bayer AG Business Overview
  15.12.5 Bayer AG Recent Developments
15.13 Clarity Pharmaceuticals
  15.13.1 Clarity Pharmaceuticals Basic Information
  15.13.2 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Overview
  15.13.3 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Market Performance
  15.13.4 Clarity Pharmaceuticals Business Overview
  15.13.5 Clarity Pharmaceuticals Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radiopharmaceutical Theranostics Market Size by Type (M USD)
Table 4. Global Radiopharmaceutical Theranostics Market Size by Application (M USD)
Table 5. Radiopharmaceutical Theranostics Market Size Comparison by Region (M USD)
Table 6. Global Radiopharmaceutical Theranostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceutical Theranostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceutical Theranostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radiopharmaceutical Theranostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Theranostics as of 2024)
Table 11. Global Market Radiopharmaceutical Theranostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Radiopharmaceutical Theranostics Manufacturing Sites and Area Served
Table 13. Manufacturers Radiopharmaceutical Theranostics Product Type
Table 14. Global Radiopharmaceutical Theranostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceutical Theranostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Radiopharmaceutical Theranostics Market Size Comparison by Region (M USD)
Table 26. Global Radiopharmaceutical Theranostics Market Size by Region (2020-2033) & (M USD)
Table 27. Global Radiopharmaceutical Theranostics Market Size Market Share by Region (2020-2033)
Table 28. Global Radiopharmaceutical Theranostics Sales by Region (2020-2033) & (K Units)
Table 29. Global Radiopharmaceutical Theranostics Sales Market Share by Region (2020-2033)
Table 30. North America Radiopharmaceutical Theranostics Market Size by Country (2020-2033) & (M USD)
Table 31. North America Radiopharmaceutical Theranostics Sales by Country (2020-2033) & (K Units)
Table 32. North America Radiopharmaceutical Theranostics Sales by Type (K Units)
Table 33. North America Radiopharmaceutical Theranostics Market Size by Type (M USD)
Table 34. North America Radiopharmaceutical Theranostics Sales (K Units) by Type (2020-2033)
Table 35. North America Radiopharmaceutical Theranostics Market Size (M USD) by Type (2020-2033)
Table 36. North America Radiopharmaceutical Theranostics Sales by Application (K Units)
Table 37. North America Radiopharmaceutical Theranostics Market Size by Application (M USD)
Table 38. North America Radiopharmaceutical Theranostics Sales (K Units) by Application (2020-2033)
Table 39. North America Radiopharmaceutical Theranostics Market Size (M USD) by Application (2020-2033)
Table 40. Europe Radiopharmaceutical Theranostics Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Radiopharmaceutical Theranostics Sales by Country (2020-2033) & (K Units)
Table 42. Europe Radiopharmaceutical Theranostics Sales by Type (K Units)
Table 43. Europe Radiopharmaceutical Theranostics Market Size by Type (M USD)
Table 44. Europe Radiopharmaceutical Theranostics Sales (K Units) by Type (2020-2033)
Table 45. Europe Radiopharmaceutical Theranostics Market Size (M USD) by Type (2020-2033)
Table 46. Europe Radiopharmaceutical Theranostics Sales by Application (K Units)
Table 47. Europe Radiopharmaceutical Theranostics Market Size by Application (M USD)
Table 48. Europe Radiopharmaceutical Theranostics Sales (K Units) by Application (2020-2033)
Table 49. Europe Radiopharmaceutical Theranostics Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Radiopharmaceutical Theranostics Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Radiopharmaceutical Theranostics Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Radiopharmaceutical Theranostics Sales by Type (K Units)
Table 53. Asia-Pacific Radiopharmaceutical Theranostics Market Size by Type (M USD)
Table 54. Asia-Pacific Radiopharmaceutical Theranostics Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Radiopharmaceutical Theranostics Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Radiopharmaceutical Theranostics Sales by Application (K Units)
Table 57. Asia-Pacific Radiopharmaceutical Theranostics Market Size by Application (M USD)
Table 58. Asia-Pacific Radiopharmaceutical Theranostics Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Radiopharmaceutical Theranostics Market Size (M USD) by Application (2020-2025)
Table 60. South America Radiopharmaceutical Theranostics Market Size by Country (2020-2033) & (M USD)
Table 61. South America Radiopharmaceutical Theranostics Sales by Country (2020-2033) & (K Units)
Table 62. South America Radiopharmaceutical Theranostics Sales by Type (K Units)
Table 63. South America Radiopharmaceutical Theranostics Market Size by Type (M USD)
Table 64. South America Radiopharmaceutical Theranostics Sales (K Units) by Type (2020-2033)
Table 65. South America Radiopharmaceutical Theranostics Market Size (M USD) by Type (2020-2033)
Table 66. South America Radiopharmaceutical Theranostics Sales by Application (K Units)
Table 67. South America Radiopharmaceutical Theranostics Market Size by Application (M USD)
Table 68. South America Radiopharmaceutical Theranostics Sales (K Units) by Application (2020-2033)
Table 69. South America Radiopharmaceutical Theranostics Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Radiopharmaceutical Theranostics Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Radiopharmaceutical Theranostics Sales by Type (K Units)
Table 73. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Type (M USD)
Table 74. Middle East and Africa Radiopharmaceutical Theranostics Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Radiopharmaceutical Theranostics Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Radiopharmaceutical Theranostics Sales by Application (K Units)
Table 77. Middle East and Africa Radiopharmaceutical Theranostics Market Size by Application (M USD)
Table 78. Middle East and Africa Radiopharmaceutical Theranostics Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Radiopharmaceutical Theranostics Market Size (M USD) by Application (2020-2033)
Table 80. Global Radiopharmaceutical Theranostics Production (K Units) by Region(2020-2025)
Table 81. Global Radiopharmaceutical Theranostics Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Radiopharmaceutical Theranostics Revenue Market Share by Region (2020-2025)
Table 83. Global Radiopharmaceutical Theranostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Radiopharmaceutical Theranostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Radiopharmaceutical Theranostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Radiopharmaceutical Theranostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Radiopharmaceutical Theranostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Radiopharmaceutical Theranostics Sales by Type (K Units)
Table 89. Global Radiopharmaceutical Theranostics Market Size by Type (M USD)
Table 90. Global Radiopharmaceutical Theranostics Sales (K Units) by Type (2020-2033)
Table 91. Global Radiopharmaceutical Theranostics Sales Market Share by Type (2020-2033)
Table 92. Global Radiopharmaceutical Theranostics Market Size (M USD) by Type (2020-2033)
Table 93. Global Radiopharmaceutical Theranostics Market Size Share by Type (2020-2033)
Table 94. Global Radiopharmaceutical Theranostics Sales (K Units) by Application
Table 95. Global Radiopharmaceutical Theranostics Market Size by Application(M USD)
Table 96. Global Radiopharmaceutical Theranostics Sales by Application (2020-2033) & (K Units)
Table 97. Global Radiopharmaceutical Theranostics Sales Market Share by Application (2020-2033)
Table 98. Global Radiopharmaceutical Theranostics Market Size by Application (2020-2033) & (M USD)
Table 99. Global Radiopharmaceutical Theranostics Market Share by Application (2020-2033)
Table 100. Global Radiopharmaceutical Theranostics Sales Growth Rate by Application (2020-2033)
Table 101. Nihon Medi-Physics Basic Information
Table 102. Nihon Medi-Physics Radiopharmaceutical Theranostics Product Overview
Table 103. Nihon Medi-Physics Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Nihon Medi-Physics Business Overview
Table 105. Nihon Medi-Physics SWOT Analysis
Table 106. Nihon Medi-Physics Recent Developments
Table 107. ITM Isotopen Technologien Mьnchen AG Basic Information
Table 108. ITM Isotopen Technologien Mьnchen AG Radiopharmaceutical Theranostics Product Overview
Table 109. ITM Isotopen Technologien Mьnchen AG Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. ITM Isotopen Technologien Mьnchen AG Business Overview
Table 111. ITM Isotopen Technologien Mьnchen AG SWOT Analysis
Table 112. ITM Isotopen Technologien Mьnchen AG Recent Developments
Table 113. Advanced Accelerator Applications Basic Information
Table 114. Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Overview
Table 115. Advanced Accelerator Applications Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Advanced Accelerator Applications Business Overview
Table 117. Advanced Accelerator Applications SWOT Analysis
Table 118. Advanced Accelerator Applications Recent Developments
Table 119. Telix Pharmaceuticals Basic Information
Table 120. Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Overview
Table 121. Telix Pharmaceuticals Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Telix Pharmaceuticals Business Overview
Table 123. Telix Pharmaceuticals Recent Developments
Table 124. GE Healthcare Basic Information
Table 125. GE Healthcare Radiopharmaceutical Theranostics Product Overview
Table 126. GE Healthcare Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. GE Healthcare Business Overview
Table 128. GE Healthcare Recent Developments
Table 129. Theragnostics Ltd. Basic Information
Table 130. Theragnostics Ltd. Radiopharmaceutical Theranostics Product Overview
Table 131. Theragnostics Ltd. Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Theragnostics Ltd. Business Overview
Table 133. Theragnostics Ltd. Recent Developments
Table 134. NuView Life Sciences Basic Information
Table 135. NuView Life Sciences Radiopharmaceutical Theranostics Product Overview
Table 136. NuView Life Sciences Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. NuView Life Sciences Business Overview
Table 138. NuView Life Sciences Recent Developments
Table 139. Jubilant Pharma Limited Basic Information
Table 140. Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Overview
Table 141. Jubilant Pharma Limited Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Jubilant Pharma Limited Business Overview
Table 143. Jubilant Pharma Limited Recent Developments
Table 144. Lantheus Holdings Basic Information
Table 145. Lantheus Holdings Radiopharmaceutical Theranostics Product Overview
Table 146. Lantheus Holdings Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Lantheus Holdings Business Overview
Table 148. Lantheus Holdings Recent Developments
Table 149. Inc. Basic Information
Table 150. Inc. Radiopharmaceutical Theranostics Product Overview
Table 151. Inc. Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Inc. Business Overview
Table 153. Inc. Recent Developments
Table 154. Curium Pharma Basic Information
Table 155. Curium Pharma Radiopharmaceutical Theranostics Product Overview
Table 156. Curium Pharma Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Curium Pharma Business Overview
Table 158. Curium Pharma Recent Developments
Table 159. Bayer AG Basic Information
Table 160. Bayer AG Radiopharmaceutical Theranostics Product Overview
Table 161. Bayer AG Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Bayer AG Business Overview
Table 163. Bayer AG Recent Developments
Table 164. Clarity Pharmaceuticals Basic Information
Table 165. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Overview
Table 166. Clarity Pharmaceuticals Radiopharmaceutical Theranostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Clarity Pharmaceuticals Business Overview
Table 168. Clarity Pharmaceuticals Recent Developments
List of Figures
Figure 1. Product Picture of Radiopharmaceutical Theranostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceutical Theranostics Market Size (M USD), 2024-2033
Figure 5. Global Radiopharmaceutical Theranostics Market Size (M USD) (2020-2033)
Figure 6. Global Radiopharmaceutical Theranostics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceutical Theranostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceutical Theranostics Product Life Cycle
Figure 13. Radiopharmaceutical Theranostics Sales Share by Manufacturers in 2024
Figure 14. Global Radiopharmaceutical Theranostics Revenue Share by Manufacturers in 2024
Figure 15. Radiopharmaceutical Theranostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Radiopharmaceutical Theranostics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Theranostics Revenue in 2024
Figure 18. Industry Chain Map of Radiopharmaceutical Theranostics
Figure 19. Global Radiopharmaceutical Theranostics Market PEST Analysis
Figure 20. Global Radiopharmaceutical Theranostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Radiopharmaceutical Theranostics Market Size by Region
Figure 27. Global Radiopharmaceutical Theranostics Market Size Market Share by Region (2020-2033)
Figure 28. Global Radiopharmaceutical Theranostics Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Radiopharmaceutical Theranostics Market Size (M USD) by Country
Figure 33. USA Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Radiopharmaceutical Theranostics Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Radiopharmaceutical Theranostics Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Radiopharmaceutical Theranostics Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Radiopharmaceutical Theranostics Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Radiopharmaceutical Theranostics Market Size (M USD)by Type
Figure 40. North America Radiopharmaceutical Theranostics Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Radiopharmaceutical Theranostics Market Size (M USD) by Country
Figure 45. Germany Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Radiopharmaceutical Theranostics Market Size (M USD) by Type
Figure 56. Europe Radiopharmaceutical Theranostics Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Radiopharmaceutical Theranostics Market Size (M USD) by Country
Figure 61. China Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Radiopharmaceutical Theranostics Market Size (M USD) by Type
Figure 72. Asia-Pacific Radiopharmaceutical Theranostics Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Radiopharmaceutical Theranostics Market Size (M USD) by Country
Figure 77. Brazil Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Radiopharmaceutical Theranostics Market Size (M USD) by Type
Figure 84. South America Radiopharmaceutical Theranostics Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceutical Theranostics Market Size (M USD) by Country
Figure 89. Saudi Arabia Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Radiopharmaceutical Theranostics Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Radiopharmaceutical Theranostics Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Radiopharmaceutical Theranostics Market Size (M USD) by Type
Figure 100. Middle East and Africa Radiopharmaceutical Theranostics Market Size (M USD) by Application
Figure 101. Global Radiopharmaceutical Theranostics Production Market Share by Region (2020-2025)
Figure 102. North America Radiopharmaceutical Theranostics Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Radiopharmaceutical Theranostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Radiopharmaceutical Theranostics Production (K Units) Growth Rate (2020-2025)
Figure 105. China Radiopharmaceutical Theranostics Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Radiopharmaceutical Theranostics Market Size by Type (M USD)
Figure 108. Sales Market Share of Radiopharmaceutical Theranostics by Type (2020-2033)
Figure 109. Sales Market Share of Radiopharmaceutical Theranostics by Type in 2024
Figure 110. Market Size Share of Radiopharmaceutical Theranostics by Type (2020-2033)
Figure 111. Market Size Share of Radiopharmaceutical Theranostics by Type in 2024
Figure 112. Global Radiopharmaceutical Theranostics Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Radiopharmaceutical Theranostics Market Size by Application(M USD)
Figure 115. Global Radiopharmaceutical Theranostics Market Share by Application
Figure 116. Global Radiopharmaceutical Theranostics Sales Market Share by Application (2020-2033)
Figure 117. Global Radiopharmaceutical Theranostics Sales Market Share by Application in 2024
Figure 118. Global Radiopharmaceutical Theranostics Market Share by Application (2020-2033)
Figure 119. Global Radiopharmaceutical Theranostics Market Share by Application in 2024
Figure 120. Global Radiopharmaceutical Theranostics Sales Growth Rate by Application (2020-2033)